Sign in
Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity
Journal article   Open access   Peer reviewed

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity

Mohan Patil, Ilaria Casari, Dinesh Thapa, Leon N. Warne, Elena Dallerba, Massimiliano Massi, Rodrigo Carlessi and Marco Falasca
Biomedicine & pharmacotherapy, Vol.177, 117077
2024
pdf
Published10.54 MBDownloadView
CC BY-NC V4.0 Open Access

Abstract

GLP-1 obesity pharmacodynamics pharmacokinetics Synthetic GPR119 agonists toxicity type-2 diabetes

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Metrics

3 File views/ downloads
44 Record Views
Logo image